DFB Pharmaceuticals is a private investment group with an entrepreneurial drive for developing new products and businesses in healthcare. DFB and its principals have established a successful track record of creating value through strategic acquisitions of companies and technologies, internal product development, brand optimization, and pharmaceutical operations.
View Top Employees from DFB Pharmaceuticals LLCWebsite | http://www.dfb.com |
Revenue | $1 million |
Funding | $150000 |
Employees | 10 (8 on RocketReach) |
Address | 3909 Hulen St, Fort Worth, Texas 76107, US |
Phone | (817) 900-4050 |
Technologies |
JavaScript,
HTML,
Twitter
+3 more
(view full list)
|
Industry | Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Venture Capital, Financial Services, Lending and Investments |
Competitors | Agile Therapeutics, AmexDrug Corporation, Angiotech Pharmaceuticals, Lipocine Inc., MediciNova, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular DFB Pharmaceuticals LLC employee's phone or email?
The DFB Pharmaceuticals LLC annual revenue was $1 million in 2023.
Maxwell Lea is the Managing Director of DFB Pharmaceuticals LLC.
8 people are employed at DFB Pharmaceuticals LLC.
DFB Pharmaceuticals LLC is based in Fort Worth, Texas.
The NAICS codes for DFB Pharmaceuticals LLC are [32, 3254, 32541, 325].
The SIC codes for DFB Pharmaceuticals LLC are [28, 283].